Article
作者: Bianchi, Siro ; Lanzavecchia, Antonio ; Low, Jun Siong ; Culap, Katja ; Benigni, Fabio ; Giannini, Olivier ; Cameroni, Elisabetta ; Pinto, Dora ; Sallusto, Federica ; Riva, Agostino ; Noack, Julia ; Bowen, John E. ; Cippà, Pietro E. ; Silacci-Fregni, Chiara ; Smithey, Megan ; Jaconi, Stefano ; Pizzuto, Matteo S. ; Telenti, Amalio ; Bassi, Jessica ; Jerak, Josipa ; Veesler, David ; Ceschi, Alessandro ; Abdelnabi, Rana ; Kaiser, Hannah ; Bartha, Istvan ; di Iulio, Julia ; Piccoli, Luca ; Coelmont, Lotte ; Guarino, Barbara ; Sauer, Maximilian M. ; Marzi, Roberta ; Vetti, Eneida ; Beltramello, Martina ; Hong, David ; Virgin, Herbert W. ; Havenar-Daughton, Colin ; Sprugasci, Nicole ; Snell, Gyorgy ; Czudnochowski, Nadine ; Neyts, Johan ; Cassotta, Antonino ; Ceruti, Samuele ; Islam, Saiful ; Foo, Caroline ; Housley, Michael P. ; Walls, Alexandra C. ; Tortorici, M. Alejandra ; Corti, Davide ; Garzoni, Christian ; Lempp, Florian A. ; Ferrari, Paolo ; Rosen, Laura E.
Targeting a range of betacoranaviruses
In the past 20 years, three highly pathogenic β-coronaviruses have crossed from animals to humans, including the most recent: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A spike protein that decorates these viruses has an S1 domain that binds host cell receptors and an S2 domain that fuses the viral and cell membranes to allow cell entry. The S1 domain is the target of many neutralizing antibodies but is more genetically variable than S2, and antibodies can exert selective pressure, leading to resistant variants. Pinto
et al
. identified five monoclonal antibodies that interact with a helix in the S2 domain. The most broadly neutralizing antibody inhibited all β-coronavirus subgenera and reduced viral burden in hamsters infected with SARS-CoV-2. —VV
